210 related articles for article (PubMed ID: 3366932)
1. Immunohistological demonstration of progesterone receptor in breast carcinomas: correlation with radioligand binding assays and oestrogen receptor immunohistology.
Giri DD; Goepel JR; Rogers K; Underwood JC
J Clin Pathol; 1988 Apr; 41(4):444-7. PubMed ID: 3366932
[TBL] [Abstract][Full Text] [Related]
2. Immunohistology of oestrogen receptor and D5 antigen in breast cancer: correlation with oestrogen receptor content of adjacent cryostat sections assayed by radioligand binding and enzyme immunoassay.
Giri DD; Dangerfield VJ; Lonsdale R; Rogers K; Underwood JC
J Clin Pathol; 1987 Jul; 40(7):734-40. PubMed ID: 3305584
[TBL] [Abstract][Full Text] [Related]
3. Oestrogen and progesterone receptors in screen-detected breast carcinoma: an immunohistological study using paraffin sections.
Soomro S; Shousha S; Sinnett HD
Histopathology; 1992 Dec; 21(6):543-7. PubMed ID: 1468753
[TBL] [Abstract][Full Text] [Related]
4. Imprint cytology in immunocytochemical analysis of oestrogen and progesterone receptors of breast carcinoma.
Helin HJ; Isola JJ; Helin MJ; Helle MJ; Krohn KJ
J Clin Pathol; 1989 Oct; 42(10):1043-5. PubMed ID: 2685049
[TBL] [Abstract][Full Text] [Related]
5. Immunohistological study of oestrogen receptors in breast carcinomas that are biochemically receptor negative.
Shousha S; Stamp T; James KR; Alaghband-Zadeh J
J Clin Pathol; 1990 Mar; 43(3):239-42. PubMed ID: 1692041
[TBL] [Abstract][Full Text] [Related]
6. Oestrogen receptor negative-progesterone receptor positive phenotype in 1,211 breast tumours.
Pichon MF; Milgrom E
Br J Cancer; 1992 Jun; 65(6):895-7. PubMed ID: 1616860
[TBL] [Abstract][Full Text] [Related]
7. Oestrogen and progesterone receptor content and the distribution of histological grade in breast cancer.
Thoresen S; Thorsen T; Tangen M; Hartveit F
Breast Cancer Res Treat; 1982; 2(3):251-5. PubMed ID: 7150780
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous quantification of oestrogen and progesterone receptors by a ligand binding assay in frozen sections.
Vollmer G; Helmchen B; Knuppen R
J Clin Chem Clin Biochem; 1989 Dec; 27(12):953-9. PubMed ID: 2614342
[TBL] [Abstract][Full Text] [Related]
9. Measurement of nuclear oestrogen receptors in human breast tumours.
Mountjoy KG; Ross JM; Marshall AM; Evans MC; Holdaway IM
Aust N Z J Surg; 1989 Jun; 59(6):499-504. PubMed ID: 2735878
[TBL] [Abstract][Full Text] [Related]
10. Progesterone and oestrogen receptors in human breast cancer.
Holdaway IM; Mountjoy KG
Aust N Z J Med; 1978 Dec; 8(6):630-8. PubMed ID: 285684
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of oestrogen and progesterone receptors on fine-needle aspirates and cryostat sections of breast carcinomas: how does this compare with biochemical assays?
Muchiri LW
East Afr Med J; 1993 May; 70(5):280-3. PubMed ID: 8306903
[TBL] [Abstract][Full Text] [Related]
12. Cytosol and nuclear estrogen receptors (occupied and unoccupied sites) and progesterone receptors in human breast cancer.
Sumida C; Magdelenat H; Pasqualini JR
Breast Cancer Res Treat; 1985; 5(2):165-9. PubMed ID: 4016282
[TBL] [Abstract][Full Text] [Related]
13. Estimation of PR and ER by immunocytochemistry in breast cancer. Comparison with radioligand binding methods.
Seymour L; Meyer K; Esser J; MacPhail AP; Behr A; Bezwoda WR
Am J Clin Pathol; 1990 Oct; 94(4 Suppl 1):S35-40. PubMed ID: 1699410
[TBL] [Abstract][Full Text] [Related]
14. Quantitative monoclonal antibody determination of estrogen and progesterone receptors in human breast cancer: correlation with the radioligand method.
Jarque F; Lluch A; Vizcarra E; Muñoz M; Alberola V; Garciá-Conde J
Oncology; 1994; 51(5):435-9. PubMed ID: 8052485
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric analysis (SAMBA 200) of the progesterone receptor immunocytochemical assay in nonmalignant and malignant breast disorders.
Charpin C; Jacquemier J; Andrac L; Vacheret H; Habib MC; Devictor B; Lavaut MN; Toga M
Am J Pathol; 1988 Aug; 132(2):199-211. PubMed ID: 2456699
[TBL] [Abstract][Full Text] [Related]
16. The incidence of positive oestrogen and progesterone receptors in breast cancer of Greek women.
Vassilaros S; Adamopoulos DA; Papadiamantis J; Dessypris A; Kapolla N
Anticancer Res; 1981; 1(4):195-7. PubMed ID: 7345966
[TBL] [Abstract][Full Text] [Related]
17. Oestrogen, progesterone, and androgen receptors in ovarian neoplasia: correlation between immunohistochemical and biochemical receptor analyses.
van Doorn HC; Burger CW; van der Valk P; Bonfrèr HM
J Clin Pathol; 2000 Mar; 53(3):201-5. PubMed ID: 10823139
[TBL] [Abstract][Full Text] [Related]
18. Progesterone receptor determination in human breast tumors by immunocytochemical and biochemical techniques.
Cappelletti V; Patriarca C; Granata G; Cattoretti G; Coradini D; Di Fronzo G; Horwitz K
Breast Cancer Res Treat; 1989 Nov; 14(2):217-25. PubMed ID: 2690973
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of enzyme immunoassay and tritiated steroid binding assay for estrogen and progesterone receptor in 56 breast cancer cytosols].
Noguchi S; Miyauchi K; Nishizawa Y; Koyama H
Nihon Gan Chiryo Gakkai Shi; 1988 Jun; 23(6):1257-64. PubMed ID: 3068322
[No Abstract] [Full Text] [Related]
20. Detection of P24 protein in human breast cancer: influence of receptor status and oestrogen exposure.
Seymour L; Bezwoda WR; Meyer K; Behr C
Br J Cancer; 1990 Jun; 61(6):886-90. PubMed ID: 2372491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
